These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9280496)

  • 1. [Experimental evaluation of the use of recombinant prourokinase and its immobilized forms in the treatment of postoperative fibrinoid syndrome in ophthalmology].
    Boĭko EV; Danilichev VF; Kol'tsova SV
    Biull Eksp Biol Med; 1997 Feb; 123(2):201-4. PubMed ID: 9280496
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial prourokinase for acute ischemic stroke.
    Tirschwell D
    JAMA; 2000 Apr; 283(16):2103; author reply 2103-4. PubMed ID: 10791497
    [No Abstract]   [Full Text] [Related]  

  • 3. Intra-arterial prourokinase for acute ischemic stroke.
    Schneweis S; Grond M
    JAMA; 2000 Apr; 283(16):2102-3; author reply 2103-4. PubMed ID: 10791496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Local fibrinolysis of hypertensive intracerebral hematomas].
    Saribekian AS; Arzamastsev EV; Bibilashvili RSh; Golubykh VL; Belogurov AA; Poliakova LN; Ponomarev VA
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):14-9; discussion 19-20. PubMed ID: 19062590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment policy using recombinant prourokinase for submacular hemorrhages].
    Sosnovskiĭ VV; Sdobnikova SV; Revishchin AV; Surguch VK; Troitskaia NA; Sidamonidze AL; Belogurov AA; Del'ver EP; Gurskiĭ IaG
    Vestn Oftalmol; 2009; 125(4):3-8. PubMed ID: 19824437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Wegner CD; Cox BF
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin-specific thrombolytic agents.
    Collen D
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of recombinant pro-urokinase ocular dosage form].
    Aliab'eva ZhIu; Matveev MIu; Evgrafov VIu; Domogatskiĭ SP
    Vestn Oftalmol; 1998; 114(1):38-41. PubMed ID: 9584640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Soluble heteroprotein conjugates based on recombinant pro-urokinase for ophthalmology].
    Kol'tsova SV; Boĭko EV; Kuznetsova NP; Danilichev VF
    Vopr Med Khim; 1995; 41(3):13-7. PubMed ID: 8585168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin.
    Toth CA; Nasir MA; Ho CL; Mittra RA
    Retina; 1997; 17(4):315-20. PubMed ID: 9279948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can plasminogen activators be improved?
    Haber E
    Circulation; 1990 Nov; 82(5):1874-6. PubMed ID: 2121386
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug preparations of immobilized enzymes with enhanced affinity for the site of action].
    Torchilin VP; Maksimenko AV; Tishchenko EG; Papisov MI; Smirnov VN
    Antibiot Med Biotekhnol; 1986 Feb; 31(2):122-7. PubMed ID: 2421639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy. Future aspects.
    Bär FW
    Int J Clin Pract Suppl; 1998 Nov; 99():23-5. PubMed ID: 10344038
    [No Abstract]   [Full Text] [Related]  

  • 16. Urokinase-treatment of fresh laser irradiation-induced vitreous hemorrhage.
    Belkin M; Lund DJ; Beatrice ES
    Ophthalmologica; 1983; 187(3):152-6. PubMed ID: 6634062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracavitary injection of urokinase in the experimentally induced early pyogenic liver abscess of the rabbit.
    Song TJ; Cha SH; Kim BH; Chung HH; Park CM; Kim JH; Lee IO; Lee ES; Kim YS; Kim D; Park JT; Kim SJ; Choi SY; Kim YC; Seo SO; Koo BH
    Yonsei Med J; 2002 Jun; 43(3):341-5. PubMed ID: 12089742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative action of the prostacyclin analogue taprostene and the fibrinolytic prourokinase (r-scu-PA) in experimental artery thrombosis.
    Groves R; Schneider J; Flohé L
    Prog Clin Biol Res; 1989; 301():603-7. PubMed ID: 2508120
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Gandorfer A; Kampik A
    Retina; 2005; 25(2):232-3; author reply 233-4. PubMed ID: 15689824
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents].
    Araki G
    No To Shinkei; 1992 Sep; 44(9):771-7. PubMed ID: 1476806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.